U.S. market Closed. Opens in 1 day 4 hours 10 minutes

INBX | Inhibrx, Inc. Stock Fundamentals

(Stock Exchange: NASDAQ)
Analyzing fundamentals for INBX we got that it has average fundamentals where Valuation is considered to be significantly overvalued, Profitability is stunning wealthy, Growth is very bad and Health is weak.

Valuation (29%)

Company Industry
P/E Ratio (TTM) 0.13 -15.27
PEG Ratio (TTM) -0.09 -4.35
P/S Ratio (TTM) 117.63 45.97
P/B Ratio (TTM) 1.22 28.96
P/FCF Ratio (TTM) -0.96 -2.59
Price to 5YR AVG Earnings Ratio -4.61 -5.56
Price to 5YR AVG FCF Ratio -2.13 -12.33

Profitability (100%)

Company Industry
ROA (TTM) 737.70% -19.06%
ROE (TTM) 1,450.05% 15.70%
Net Profit Margin (TTM) 94,684.72% -813.88%
ROIC 5YR AVG 426.87% 3.12%

Growth (38%)

4QTR AVG 3YR AVG 5YR AVG
EPS 2,217.62% -35.52% -43.28%
Revenue 268.28% 5.91% -13.81%
Net Income 573.35% -40.07% -52.80%
Cash Flow 10.13% -51.97% -53.42%

Health (42%)

Company Industry
Current Ratio (TTM) 4.70 5.56
Quick Ratio (TTM) 4.70 5.34
D/E Ratio (TTM) N/A 0.95
Interest Coverage (TTM) -17.03 -6.44
Piotroski F-Score 2 5
Altman Z-Score 27.97 12.45
LTL to 5YR AVG FCF -2.18 0.11
Shares Outstanding Growth 5YR AVG 15.52% 37.46%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙